Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Hayward Holdings $286 million secondary offering
The stock is listed on the New York Stock Exchange
Beyond Meat $200 million at-the-market offering
The stock offering is SEC-registered
Comcast $5 billion notes offering and $2.9 billion cash tender offers
We advised Comcast in connection with the transactions
Livent $10.6 billion merger of equals with Allkem
We are advising Livent on the transaction
General Motors Financial $400 million senior notes offering
The investment-grade notes are due 2026
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction